Home LiteratureArticle Details
PMID: 12396613 Published · ppublish English Comparative Study Evaluation Study Journal Article Research Support, Non-U.S. Gov't

A human immunodeficiency virus type 1 pol gene-derived sequence (cPPT/CTS) increases the efficiency of transduction of human nondividing monocytes and T lymphocytes by lentiviral vectors.

Human gene therapy ·Vol. 13 ·No. 15 ·2002-10-10 ·Pages 1793-807

Manganini M, Serafini M, Bambacioni F, Casati C, Erba E, Follenzi A, Naldini L, Bernasconi S, Gaipa G, Rambaldi A, Biondi A, Golay J, Introna M

Abstract

We have investigated the capacity of two human immunodeficiency virus type 1-derived lentivectors, differing in the presence of a 118-bp pol fragment containing the cPPT/CTS element, to transduce human normal primary cells of different hematopoietic lineages. Infection of resting monocytes with a high multiplicity of infection (MOI > 10) revealed that the lentivirus carrying the pol fragment (cPPT) is effective, transducing 75% of cells compared with 36% for the no-cPPT vector. Even at low MOIs (< or =1) the cPPT vector still shows a better transduction efficiency than the no-cPPT vector. Moreover, transduction does not require dendritic cell differentiation. In contrast, infection of nonactivated T lymphocytes showed that both vectors, tested at high MOIs, can transduce a small, although measurable, percentage of cells (up to 10%), which may correspond to G(1a) "activated" cells as detected by simultaneous staining of DNA and RNA, in our cultures in the presence of medium alone. Furthermore, we show that the sole addition of interleukin 2 or interleukin 15 represents a full proliferative signal under our conditions and permits high transduction efficiency (up to 30% with the cPPT vector and 15% with the no-cPPT vector). Still higher transduction of T lymphocytes can be achieved after stimulation with phytohemagglutinin and interleukin 2 (up to 78% with the cPPT vector vs. 42% with the no-cPPT vector). Finally, both viruses do not transduce either resting or proliferating tonsillar B lymphocytes.

MeSH Terms
B-Lymphocytes/drug effects,virology Cell Division/drug effects Fibroblasts Genes, Reporter Genes, pol Genetic Vectors/genetics Green Fluorescent Proteins HIV-1/genetics Humans Interleukin-15/pharmacology Interleukin-2/pharmacology Kidney Luminescent Proteins/analysis,genetics Lymphoma, Follicular/pathology Moloney murine leukemia virus/genetics Monocytes/drug effects,virology Phytohemagglutinins/pharmacology T-Lymphocytes/drug effects,virology Terminal Repeat Sequences Transduction, Genetic Tumor Cells, Cultured
Chemicals
Interleukin-15 Interleukin-2 Luminescent Proteins Phytohemagglutinins Green Fluorescent Proteins
Authors & Affiliations
13 authors, click to expand affiliations / ORCID
Manganini Massimiliano
Istituto di Ricerche Farmacologiche Mario Negri, 20157 Milan, Italy.
Serafini Marta
Bambacioni Federica
Casati Chiara
Erba Eugenio
Follenzi Antonia
Naldini Luigi
Bernasconi Sergio
Gaipa Giuseppe
Rambaldi Alessandro
Biondi Andrea
Golay Josee
Introna Martino
Article Info
Journal
Human gene therapy
Abbr.
Hum Gene Ther
ISSN
1043-0342
Published
2002-10-10
Pages
1793-807
Language
English
Region
United States
NLM ID
9008950
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com